-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Ironwood Pharmaceuticals, Raises Price Target to $5

Benzinga·01/05/2026 18:35:58
语音播报
Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and raises the price target from $3 to $5.